Jw Life Science Corp (234080)

Currency in KRW
12,150
-370(-2.96%)
Closed·

234080 Financial Summary

Key Ratios

P/E Ratio4.19
Price/Book0.95
Debt / Equity32.84%
Return on Equity25.29%
Dividend Yield4.12%
EBITDA51.60B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of KRW (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2,903.66%
Dividend Yield
4.12%
Industry Median 0.93%
Annualised payout
500.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 15, 2025
EPS / Forecast
394.00 / --
Revenue / Forecast
61.30B / --
EPS Revisions
Last 90 days

FAQ

What were Jw Life Science's earnings for the latest quarter?

The Jw Life Science EPS (TTM) is 2,903.66. Jw Life Science reported sales of 76,183.37, net income of 6,107.38, and EPS of 394.00 for the latest quarter.

What was Jw Life Science's net income for the latest quarter?

Jw Life Science's net income for the latest quarter was 6,107.38.

How did Jw Life Science's performance compare year-over-year in the latest quarter?

The company's revenue moved from 54,794.80 in the previous quarter to 76,183.37 in the latest quarter, and net income moved from 25,435.63 to 6,107.38 compared to the previous quarter.

What is Jw Life Science's net profit margin on a TTM basis?

Jw Life Science's trailing twelve months (TTM) net profit margin is 19.77%.

How does Jw Life Science's debt to equity ratio compare to industry standards?

Jw Life Science's total debt-to-equity ratio is 32.84%.

What is Jw Life Science's return on investment on a TTM basis?

Jw Life Science's trailing twelve months (TTM) return on investment (ROI) is 25.29%.

Did Jw Life Science gain or lose cash last quarter?

In the latest quarter, Jw Life Science's net change in cash was -115.96 million.

What were Jw Life Science's total assets and liabilities in the latest quarter?

As of the latest quarter, Jw Life Science reported total assets of 325,105.09 million and total liabilities of 81,278.84 million.

How has Jw Life Science's total revenue grown this year?

Jw Life Science's total revenue was 54,794.80 in the previous quarter and 76,183.37 in the latest quarter.

What is Jw Life Science's gross margin on a TTM basis?

Jw Life Science's trailing twelve months (TTM) gross margin is 25.19%.

What was Jw Life Science's revenue per share for the latest quarter?

Jw Life Science's revenue per share for the latest quarter was 14,018.06.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.